首页 > 市场调查报告书 > 医疗设备

导管

市场调查报告书

商品编码

1548171

全球神经学栓塞装置市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global Embolization Devices For Neurology Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年08月01日 | 出版商:

Value Market Research | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球神经学栓塞设备市场需求预计将从 2023 年的 15.5 亿美元达到近 21.4 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 3.62%。

神经病学栓塞装置是一种专门的医疗器械，用于透过闭塞或阻塞大脑血管来治疗神经系统疾病。这些设备用于血管内栓塞等手术中，以治疗脑动脉瘤、动静脉畸形和肿瘤等疾病。常见的栓塞装置包括线圈、栓塞和液体栓塞剂，旨在诱导凝血并永久阻碍血液流向目标区域。透过减少或停止异常血管结构的血液供应，这些装置有助于预防出血、降低压力并治疗各种神经系统疾病。使用栓塞装置对于微创干预至关重要，它可以为患者提供有效的治疗选择，同时最大限度地减少手术风险和恢復时间。

市场动态

由于需要栓塞的神经系统疾病（例如脑动脉瘤和动静脉畸形（AVM））的盛行率不断增加，神经病学市场的栓塞设备正在经历成长。随着人口老化和诊断能力增强等因素的推动，这些疾病的发生率不断上升，对有效栓塞治疗的需求也不断增长。技术进步正在创造巨大的市场机会。栓塞装置材料和设计的创新，例如开发更俱生物相容性和灵活性的材料，正在提高治疗的安全性和有效性。先进影像技术与栓塞设备的整合可实现更精确和受控的手术，从而改善患者的治疗结果。

微创手术的成长趋势也推动了神经学市场栓塞设备的成长。栓塞技术为传统手术方法提供了侵入性较小的替代方案，从而缩短了恢復时间并降低了併发症的风险。这种向微创治疗的转变与人们越来越偏好最大限度地减少患者不适和缩短恢復时间的手术相一致。此外，新兴市场扩大医疗基础设施以及增加对神经病学和介入放射学的投资提供了巨大的成长机会。随着这些地区医疗保健系统的进步，在专业治疗的普及和对神经系统疾病的认识不断提高的推动下，先进栓塞设备的采用预计将会增加。然而，高成本和手术风险可能会导致神经科栓塞装置抑制市场成长。先进栓塞设备的巨额费用以及手术过程中可能出现的併发症可能会限制其广泛采用，特别是在成本敏感或资源有限的医疗机构中。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球神经病学栓塞设备市场的各个细分市场进行了包容性评估。神经病学栓塞装置产业的成长和趋势为本研究提供了整体方法。

市场区隔

神经病学栓塞设备市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按产品分类

栓塞线圈
液体栓塞系统
导流支架
动脉瘤夹
其他的

按治疗

缺血性中风解决方案
出血性中风解决方案

按指示

脑动脉瘤
动静脉畸形（AVM）
其他的

按最终用户

医院
门诊手术中心
专科诊所

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲神经病学栓塞设备市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。神经学栓塞设备市场的主要参与者包括 DePuy Synthes (Johnson & Johnson Services Inc.)、Terumo Medical Corporation、Stryker Corporation、Boston Scientific Corporation、Penumbra Inc.、Acandis GmbH、Balt Extrusion、Spartan Micro Inc.、B.布劳恩·梅尔松根股份公司。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

简介 - 市场动态
市场驱动因素
市场限制
机会
产业动态
波特五力分析
市场吸引力分析
- 按产品分類的市场吸引力分析
- 按处理方式进行的市场吸引力分析
- 按指标进行的市场吸引力分析
- 最终用户的市场吸引力分析
- 市场吸引力分析：按地区

第 4 章：价值链分析

价值链分析
原料分析
- 原料清单
- 原料厂商清单
- 主要原物料价格走势
潜在买家名单
行销管道
- 直效行销
- 间接行销
- 行销通路发展趋势

第 5 章：全球神经学栓塞设备市场分析：副产品

概述（按产品）
按产品分类的历史和预测资料分析
栓塞线圈
液体栓塞系统
导流支架
动脉瘤夹
其他的

第 6 章：全球神经学栓塞装置市场分析：依治疗分类

按治疗概述
依处理方式进行历史与预测资料分析
缺血性中风解决方案
出血性中风解决方案

第 7 章：全球神经学栓塞装置市场分析：依适应症分类

按指示概述
按指示进行历史和预测资料分析
脑动脉瘤
动静脉畸形（AVM）
其他的

第 8 章：全球神经学栓塞设备市场分析：依最终使用者分类

最终用户概述
最终用户的历史和预测数据分析
医院
门诊手术中心
专科诊所

第 9 章：全球神经学栓塞设备市场分析：依地理位置

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 10 章：神经科公司栓塞设备的竞争格局

神经病学市场竞争的栓塞装置
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 11 章：公司简介

顶级公司市占率分析
市场集中度
DePuy Synthes (Johnson & Johnson Services Inc.)

公司概况
公司收入
产品
最新动态

Terumo Medical Corporation

公司概况
公司收入
产品
最新动态

Stryker Corporation

公司概况
公司收入
产品
最新动态

Boston Scientific Corporation

公司概况
公司收入
产品
最新动态

Penumbra Inc.

公司概况
公司收入
产品
最新动态

Acandis GmbH

公司概况
公司收入
产品
最新动态

Balt Extrusion

公司概况
公司收入
产品
最新动态

Spartan Micro Inc.

公司概况
公司收入
产品
最新动态

B. Braun Melsungen AG

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR112115500

The global demand for Embolization Devices For Neurology Market is presumed to reach the market size of nearly USD 2.14 Billion by 2032 from USD 1.55 Billion in 2023 with a CAGR of 3.62% under the study period 2024-2032.

Embolization devices for neurology are specialized medical instruments used to treat neurological conditions by occluding or blocking blood vessels in the brain. These devices are employed in procedures such as endovascular embolization to manage conditions like brain aneurysms, arteriovenous malformations, and tumors. Common embolization devices include coils, plugs, and liquid embolic agents, designed to induce clotting and permanently obstruct blood flow to targeted areas. By reducing or stopping the blood supply to abnormal vascular structures, these devices help to prevent bleeding, reduce pressure, and treat various neurological disorders. Using embolization devices is crucial for minimally invasive interventions, providing patients with effective treatment options while minimizing surgical risks and recovery times.

MARKET DYNAMICS

The embolization devices for neurology market is experiencing growth attributed to the increasing prevalence of neurological conditions requiring embolization, such as brain aneurysms and arteriovenous malformations (AVMs). As the incidence of these conditions rises, driven by factors such as aging populations & enhanced diagnostic capabilities, the demand for effective embolization treatments grows. Technological advancements are creating significant opportunities in the market. Innovations in embolization device materials and designs, such as the development of more biocompatible and flexible materials, are enhancing the safety and efficacy of treatments. The integration of advanced imaging technologies with embolization devices enables more precise and controlled procedures, improving patient outcomes.

The growing trend towards minimally invasive procedures also drives the growth of embolization devices for the neurology market. Embolization techniques offer less invasive alternatives to traditional surgical approaches, leading to shorter recovery times and reduced risk of complications. This shift towards less invasive treatments aligns with the increasing preference for procedures that minimize patient discomfort and recovery time. Additionally, expanding healthcare infrastructure and increasing investment in neurology and interventional radiology in emerging markets offer substantial growth opportunities. As healthcare systems in these areas progress, the adoption of advanced embolization devices is expected to rise, driven by improved access to specialized treatments and growing awareness of neurological conditions. However, high costs and procedural risks can cause embolization devices for neurology to restrain market growth. The significant expense of advanced embolization devices and the potential for complications during procedures may limit widespread adoption, particularly in cost-sensitive or resource-constrained healthcare settings.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Embolization Devices For Neurology. The growth and trends of Embolization Devices For Neurology industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Embolization Devices For Neurology market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Embolization Coils
Liquid Embolic Systems
Flow Diversion Stents
Aneurysm Clips
Others

By Treatment

Ischemic Stroke Solutions
Hemorrhagic Stroke Solutions

By Indication

Brain Aneurysms
Arteriovenous Malformation (AVM)
Others

By End User

Hospitals
Ambulatory Surgical Centers
Specialty Clinics

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Embolization Devices For Neurology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Embolization Devices For Neurology market include DePuy Synthes (Johnson & Johnson Services Inc.), Terumo Medical Corporation, Stryker Corporation, Boston Scientific Corporation, Penumbra Inc., Acandis GmbH, Balt Extrusion, Spartan Micro Inc., B. Braun Melsungen AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. EMBOLIZATION DEVICES FOR NEUROLOGY - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Treatment
- 3.7.3 Market Attractiveness Analysis By Indication
- 3.7.4 Market Attractiveness Analysis By End User
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data Analysis By Product
5.3. Embolization Coils Historic and Forecast Sales By Regions
5.4. Liquid Embolic Systems Historic and Forecast Sales By Regions
5.5. Flow Diversion Stents Historic and Forecast Sales By Regions
5.6. Aneurysm Clips Historic and Forecast Sales By Regions
5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY MARKET ANALYSIS BY TREATMENT

6.1. Overview By Treatment
6.2. Historical and Forecast Data Analysis By Treatment
6.3. Ischemic Stroke Solutions Historic and Forecast Sales By Regions
6.4. Hemorrhagic Stroke Solutions Historic and Forecast Sales By Regions

7. GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY MARKET ANALYSIS BY INDICATION

7.1. Overview By Indication
7.2. Historical and Forecast Data Analysis By Indication
7.3. Brain Aneurysms Historic and Forecast Sales By Regions
7.4. Arteriovenous Malformation (AVM) Historic and Forecast Sales By Regions
7.5. Others Historic and Forecast Sales By Regions

8. GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY MARKET ANALYSIS BY END USER

8.1. Overview By End User
8.2. Historical and Forecast Data Analysis By End User
8.3. Hospitals Historic and Forecast Sales By Regions
8.4. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
8.5. Specialty Clinics Historic and Forecast Sales By Regions

9. GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE EMBOLIZATION DEVICES FOR NEUROLOGY COMPANIES

10.1. Embolization Devices For Neurology Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF EMBOLIZATION DEVICES FOR NEUROLOGY INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. DePuy Synthes (Johnson & Johnson Services Inc.)
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Terumo Medical Corporation
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Stryker Corporation
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Boston Scientific Corporation
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Penumbra Inc.
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Acandis GmbH
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Balt Extrusion
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Spartan Micro Inc.
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. B. Braun Melsungen AG
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments